A biodegradable gentamicin-hydroxyapatite-coating for infection prophylaxis in cementless hip prostheses

European Cells and Materials

Volumn 29, Issue , 2015, Pages 42-56

  Neut, D ^a,b   Dijkstra, R J B ^a   Thompson, J I ^c   Kavanagh, C ^d   van der Mei, H C ^a   Busscher, H J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Department of Orthopaedic Surgery ^*  (Netherlands)

^c Johnson Johnson Company   (United Kingdom)

^d DePuy Ireland   (Ireland)

Author keywords

Antibacterial efficacy; Antibiotic release; Bone ingrowth; Cementless prosthesis; Gentamicin releasing coating; Hydroxyapatite

Indexed keywords

AGAR; GENTAMICIN; HYDROXYAPATITE; POLYGLACTIN; TITANIUM; ANTIINFECTIVE AGENT; BIOMATERIAL; BONE CEMENT; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CONTAMINATION; BIODEGRADABILITY; BONE GROWTH; BONE MARROW; BONE PIN; CEMENTLESS PROSTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DOG; DRUG EFFICACY; DRUG RELEASE; FEMALE; FLUORESCENCE IMAGING; HIP ARTHROPLASTY; IN VITRO STUDY; MALE; MATERIAL COATING; MEDICAL DEVICE COMPLICATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROSTHESIS INFECTION; RABBIT; RISK REDUCTION; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TOTAL HIP PROSTHESIS; ANIMAL; BONE NAIL; BONE REGENERATION; CHEMISTRY; DRUG EFFECTS; FEMUR; HIP PROSTHESIS; MICROBIOLOGY; PHYSIOLOGY; PROSTHESIS-RELATED INFECTIONS; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCAL INFECTIONS; SURGERY; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; BONE CEMENTS; BONE NAILS; COATED MATERIALS, BIOCOMPATIBLE; DOGS; DRUG RESISTANCE, BACTERIAL; DURAPATITE; FEMALE; FEMUR; GENTAMICINS; HIP PROSTHESIS; LACTIC ACID; MALE; MICROSCOPY, ELECTRON, SCANNING; OSSEOINTEGRATION; POLYGLYCOLIC ACID; PROSTHESIS-RELATED INFECTIONS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT OUTCOME;

EID: 84920428875     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v029a04     Document Type: Article

References (56)

1. Alt V, Bitschnau A, Osterling J, Sewing A, Meyer C, Kraus R, SA Meissner SA, Wenisch S, Domann E, Schnettler R (2006) The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Biomaterials 27: 4627-4634.
2. Alt V, Bitschnau A, Böhner F, Heerich KE, Magesin E, Sewing A, Pavlidis T, Szalay G, Heiss C, Thormann U, Hartmann S, Pabst W, Wenisch S, Schnettler R (2011) Effects of gentamicin and gentamicin-RGD coatings on bone ingrowth and biocompatibility of cementless joint prostheses: an experimental study in rabbits. Acta Biomater 7: 1274-1280.
3. Bobyn JD, Stackpool GJ, Hacking SA, Tanzer M, Krygier JJ (1999) Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial. J Bone Joint Surg Br 81: 907-914.
4. Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, Fish DN, Napolitano LM, Sawyer RG, Slain D, Steinberg JP, Weinstein RA; American Society of Health-System Pharmacists (ASHP); Infectious Diseases Society of America (IDSA); Surgical Infection Society (SIS); Society for Healthcare Epidemiology of America (SHEA) (2013) Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 14: 73-156.
5. Campoccia D, Montanaro L, Arciola CR (2006) the significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterials 27: 2331-2339.
6. Dale H, Hallan G, Espehaug B, Havelin LI, Engesaeter LB (2009) Increasing risk of revision due to deep infection after hip arthroplasty. Acta Orthop 80: 639-645.
7. Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G (1999) A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Eng J Med 340: 1-8.
8. Deacon JM, Pagliaro AJ, Zelicof SB, Horowitz HW (1996) Prophylactic use of antibiotics for procedures after total joint replacement. J Bone Joint Surg Am 78: 1755-1770.
9. Dhert WJA, Klein CPAT, Jansen JA, Van der Velde AE, De Vries RC, Rozing PM, De Groot K (1993) A histological and histomorphometrical investigation of fluorapatite, magnesiumwhitlockite, and hydroxylapatite plasma-sprayed coatings in goats. J Biomed Mater Res 27: 127-138.
10. Engesaeter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin LI (2003) Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 74: 644-6451.
11. Fassbender M, Minkwitz S, Kronbach Z, Strobel C, Kadow-Romacker A, Schmidmaier G, Wildemann B (2013) Local gentamicin application does not interfere with bone healing in a rat model. Bone 55: 298-304.
12. Fitzgerald RH (1979) Microbiologic environment of the conventional operating room. Arch Surg 114: 772-775.
13. Geesink RGT, de Groot K, Klein CPAT (1987) Chemical implant fixation using hydroxyl-apatite coatings. The development of a human total hip prosthesis for chemical fixation to bone using hydroxyl-apatite coatings on titanium substrates. Clin Orthop Relat Res 225: 147-170.
14. Giavaresi G, Meani E, Sartori M, Ferrari A, Bellini D, Sacchetta AC, Meraner J, Sambri A, Vocale C, Sambri V, Fini M, Romanò CL (2014) Efficacy of antibacterial-loaded coating in an in vivo model of acutely highly contaminated implant. Int Orthop 38: 1505-1512.
15. Gristina AG (1987) Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 237: 1588-1595.
16. Hamilton H, Jamieson J (2008) Deep infection in total hip arthroplasty. Can J Surg 51: 111-117.
17. Helwig P, Morlock J, Oberst M, Hauschild O, Hübner J, Borde J, Südkamp NP, Konstantinidis L (2014) Periprosthetic joint infection-effect on quality of life. Int Orthop 38: 1077-1081.
18. Hess DJ, Henry-Stanley MJ, Wells CL (2011) Gentamicin promotes Staphylococcus aureus biofilms on silk suture. J Surg Res 170: 302-308.
19. Knobben BAS, Van Horn JR, Van der Mei HC, Busscher HJ (2006) Evaluation of measures to decrease intra-operative bacterial contamination in orthopaedic implant surgery. J Hosp Infect 62:174-180.
20. Kurtz SM, Ong KL, Lau E, Bozic KJ (2014) Impact of the economic downturn on total joint replacement demand in the United States: updated projections to 2021. J Bone Joint Surg Am 96: 624-630.
21. Malchau H, Herberts P, Eisler T, Garellick G, Söderman P (2002) The Swedish total hip replacement register. J Bone Joint Surg Am 84: 2-20.
22. Markmiller M, Weisss T, Kreuz P, Rüter A, Konrad G (2011) Partial weightbearing is not necessary after cementless total hip arthroplasty: a two-year prospective randomized study on 100 patients. Int Orthop 35:1139-1143.
23. Moojen DJF, Vogely HCh, Fleer A, Nikkels PGJ, Higham PA, Verbout AJ, Castelein RM, Dhert WJA (2009) Prophylaxis of infection and effects on osseointegration using a tobramycin-periapatite coating on titanium implants-an experimental study in the rabbit. J Orthop Res 27: 710-716.
24. Nemes S, Gordon M, Rogmark C, Rolfson O (2014) Projections of total hip replacement in Sweden from 2013 to 2030. Acta Orthop 85: 238-243.
25. Neut D, Dijkstra RJB, Thompson JI, Van der Mei HC, Busscher HJ (2011) Antibacterial efficacy of a new gentamicin-coating for cementless prostheses compared to gentamicin-loaded bone cement. J Orthop Res 29: 1654-1661.
26. Neut D, Dijkstra RJB, Thompson JI, Van der Mei HC, Busscher HJ (2012) A gentamicin-releasing coating for cementless hip prostheses-Longitudinal evaluation of efficacy using in vitro bio-optical imaging and its wide-spectrum antibacterial efficacy. J Biomed Mater Res A 100: 3220-3226.
27. Oosterbos CJM, Vogely HCh, Nijhof MW, Fleer A, Verbout AJ, Tonino AJ, Dhert WJA (2002) Osseointegration of hydroxyapatite-coated and noncoated Ti6Al4V implants in the presence of local infection: a comparative histomorphometrical study in rabbits. J Biomed Mater Res 60: 339-347.
28. Oosterbos CJM, Rahmy AIA, Tonino AJ, Witpeerd W (2004) High survival rate of hydroxyapatite-coated hip prostheses: 100 consecutive hips followed for 10 years. Acta Orthop Scand 75: 127-133.
29. Parvizi J, Suh DH, Jafari SM, Mullan A, Purtill JJ (2011) Aseptic loosening of total hip arthroplasty: infection always should be ruled out. Clin Orthop Relat Res 469: 1401-1405.
30. Radin S, Campbell JT, Ducheyne P, Cuckler JM (1997) Calcium phosphate ceramic coatings as carriers of vancomycin. Biomaterials 18: 777-782.
31. Reignier C, Barbour V (2011) Manufacturing Process: All White Powder Is Not HA. In: Vidalain J-P, Selmi TAS, Beverland D, Young S, Board T, Brumby S, editors. The CORAIL® Hip System: A Practical Approach Based on 25 Years of Experience. Springer, pages 31-34.
32. Richmond J (2002) Refinement, reduction, and replacement of animal use for regulatory testing: future improvements and implementation within the regulatory framework. ILAR J 43: S63-68.
33. Rigby KM, DeLeo FR (2012) Neutrophils in innate host defense against Staphylococcus aureus infections. Semin Immunopathol 34: 237-259.
34. Schmidmaier G, Lucke M, Wildemann B, Haas NP, Raschke M (2006) Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury 37: S105-112.
35. Schutte RJ, Xie L, Klitzman B, Reichert WM (2009) In vivo cytokine-associated responses to biomaterials. Biomaterials 30: 160-168.
36. Søballe K, Hansen ES, Brockstedt-Rasmussen H, Pedersen CM, Bünger C (1990) Hydroxyapatite coating enhances fixation of porous coated implants. A comparison in dogs between press fit and noninterference fit. Acta Orthop Scand 61: 299-306.
37. Søballe K, Hansen ES, Brockstedt-Rasmussen H, Bünger C (1993) Hydroxyapatite coating converts fibrous tissue to bone around loaded implants. J Bone Joint Surg Br 75: 270-278.
38. Sossai D, Dagnino G, Sanguineti F, Franchin F (2011) Mobile laminar air flow screen for additional operating room ventilation: reduction of intraoperative bacterial contamination during total knee arthroplasty. J Orthop Traumatol 12: 207-211.
39. Stigter M, de Groot K, Layrolle P (2002) Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium. Biomaterials 23: 4143-4153.
40. Stigter M, Bezemer J, de Groot K, Layroll P (2004). Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release 99: 127-137.
41. Subbiahdoss G, Kuijer R, Busscher HJ, Van der Mei HC (2010) Mammalian cell growth versus biofilm formation on biomaterial surfaces in an in vitro post-operative contamination model. Microbiology 156: 3073-3078.
42. Thomes B, Murray P, Bouchier-Hayes D (2002) Development of resistant strains of Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo. J Bone Joint Surg Br 84: 758-760.
43. Tunney MM, Dunne N, Einarsson G, McDowell A, Kerr A, Patrick S (2007) Biofilm formation by bacteria isolated from retrieved failed prosthetic hip implants in an in vitro model of hip arthroplasty antibiotic prophylaxis. J Orthop Res 25: 2-10.
44. Turner AS. Animal models of osteoporosis-necessity and limitations (2001) Eur Cell Mater 1: 66-81.
45. Vanhegan IS, Malik AK, Jayakumar P, Ul Islam S, Haddad FS (2012) A financial analysis of revision hip arthroplasty: The economic burden in relation to the national tariff. J Bone Joint Surg Br 94: 619-623.
46. Verkkala K, Eklund A, Ojajärvi J, Tiittanen L, Hoborn J, Mäkelä P (1998) The conventionally ventilated operating theatre and air contamination control during cardiac surgery-bacteriological and particulate matter control garment options for low level contamination. Eur J Cardiothorac Surg 14: 206-210.
47. Vogely HCh, Oosterbos CJM, Puts EWA, Nijhof MW, Nikkels PGJ, Fleer A, Tonino AJ, Dhert WJA, Verbout AJ (2000) Effects of hydroxyapatite coating on Ti-6A1-4V implant-site infection in a rabbit tibial model. J Orthop Res 18: 485-493.
48. Waldman BJ, Mont MA, Hungerford DS (1997) Total knee arthroplasty infections associated with dental procedures. Clin Orthop Relat Res 343: 164-172.
49. Wang J, Zhu C, Cheng T, Peng X, Zhang W, Qin H, Zhang X (2013) A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty. PLoS One 8: e82745.
50. Wu P, Grainger DW (2006) Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials 27: 2450-2467.
51. Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351: 1645-1654.
52. OECD, “Health at a glance 2011” Report, OECD Publishing 2011, p. 92-93. Available from URL: http:/?www.oecd.org/els/health-systems/49105858.pdf [14-05-2014].
53. Dunbar MJ. Cemented femoral fixation: the North Atlantic divide. Orthopedics 2009;32. Available from URL: http://www.healio.com/orthopedics/hip/journals?ORTHO/%7BF053ED41-0247-4B1F-B693-366B47958039%7D/Cemented-Femoral-Fixation-The-North-Atlantic-Divide?full=1 [14-05-2014].
54. DePuy International Ltd. An implantable medical device. International patent PCT/EP2009/063588. Online 2010. Available from URL: http://patentscope.wipo.int/search/en/WO2010043710 [14-05-2014].
55. Science, Medicine, and Animals. Committee to Update Science, Medicine, and Animals; Institute for Laboratory Animal Research; Division on Earth and Life Studies; National Research Council. National Academies Press, Washington DC, US, 2004. Safety Testing, available from URL: http://www.ncbi.nlm.nih.gov/books/NBK24645?[14-05-2014].
56. European Commission, Scientific Committee on Health and Environmental Risks, 2009. Non-human primates in research and safety testing. Available from URL: http:/?ec.europa.eu/health/opinions/en/non-human-primates/l-3/2-research-safety-testing.htm [14-05-2014].